Avalon BioVentures I, LP - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 3, 2024, Avalon BioVentures I, LP's relationship to Janux Therapeutics, Inc. (JANX) is TenPercentOwner, and currently has 3,340,018 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JANX insiders.
Data Source: SEC.
Avalon BioVentures I, LP - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 4, 2024 | Sell -- (Common Stock) | 131196 | 54.75 | 633673 |
| Jun 4, 2024 | Sell -- (Common Stock) | 677279 | 54.75 | 3271216 |
| Jun 4, 2024 | Sell -- (Common Stock) | 691525 | 54.75 | 3340018 |